Lu M - Search Results

1

Identification of the earliest prethymic T-cell progenitors in murine fetal blood.

Ikawa T, Masuda K, Lu M, Minato N, Katsura Y, Kawamoto H. Ikawa T, et al. Among authors: lu m. Blood. 2004 Jan 15;103(2):530-7. doi: 10.1182/blood-2003-06-1797. Epub 2003 Sep 25. Blood. 2004. PMID: 14512296 Free article.

2

Extensive proliferation of T cell lineage-restricted progenitors in the thymus: an essential process for clonal expression of diverse T cell receptor beta chains.

Kawamoto H, Ohmura K, Fujimoto S, Lu M, Ikawa T, Katsura Y. Kawamoto H, et al. Among authors: lu m. Eur J Immunol. 2003 Mar;33(3):606-15. doi: 10.1002/eji.200323461. Eur J Immunol. 2003. PMID: 12616481 Free article.

3

T/NK bipotent progenitors in the thymus retain the potential to generate dendritic cells.

Shen HQ, Lu M, Ikawa T, Masuda K, Ohmura K, Minato N, Katsura Y, Kawamoto H. Shen HQ, et al. Among authors: lu m. J Immunol. 2003 Oct 1;171(7):3401-6. doi: 10.4049/jimmunol.171.7.3401. J Immunol. 2003. PMID: 14500634

4

The earliest thymic progenitors in adults are restricted to T, NK, and dendritic cell lineage and have a potential to form more diverse TCRbeta chains than fetal progenitors.

Lu M, Tayu R, Ikawa T, Masuda K, Matsumoto I, Mugishima H, Kawamoto H, Katsura Y. Lu M, et al. J Immunol. 2005 Nov 1;175(9):5848-56. doi: 10.4049/jimmunol.175.9.5848. J Immunol. 2005. PMID: 16237077

5

The common myelolymphoid progenitor: a key intermediate stage in hemopoiesis generating T and B cells.

Lu M, Kawamoto H, Katsube Y, Ikawa T, Katsura Y. Lu M, et al. J Immunol. 2002 Oct 1;169(7):3519-25. doi: 10.4049/jimmunol.169.7.3519. J Immunol. 2002. PMID: 12244141

6

Immature multipotent hemopoietic progenitors lacking long-term bone marrow-reconstituting activity in the aorta-gonad-mesonephros region of murine day 10 fetuses.

Ohmura K, Kawamoto H, Lu M, Ikawa T, Ozaki S, Nakao K, Katsura Y. Ohmura K, et al. Among authors: lu m. J Immunol. 2001 Mar 1;166(5):3290-6. doi: 10.4049/jimmunol.166.5.3290. J Immunol. 2001. PMID: 11207284

7

Proteasome inhibitor and lymphocyte function: partial inhibition of cell-mediated cytotoxicity and implication that the lymphocyte proteasome may contain multiple chymotryptic domains.

Kitson RP, Lu M, Siman R, Goldfarb RH. Kitson RP, et al. Among authors: lu m. In Vivo. 2000 Jan-Feb;14(1):265-8. In Vivo. 2000. PMID: 10757085

8

Differential effects of proteasome inhibitors on cell cycle and apoptotic pathways in human YT and Jurkat cells.

Lu M, Dou QP, Kitson RP, Smith DM, Goldfarb RH. Lu M, et al. J Cell Biochem. 2006 Jan 1;97(1):122-34. doi: 10.1002/jcb.20543. J Cell Biochem. 2006. PMID: 16173095

9

Activation of multiple caspases and modification of cell surface fas (CD95) in proteasome inhibitor-induced apoptosis of rat natural killer cells.

Lu M, Kitson RP, Xue Y, Goldfarb RH. Lu M, et al. J Cell Biochem. 2003 Feb 15;88(3):482-92. doi: 10.1002/jcb.10296. J Cell Biochem. 2003. PMID: 12532325

10

Mapping the intellectual structure and emerging trends on nanomaterials in colorectal cancer: a bibliometric analysis from 2003 to 2024.

Lu M, Liu Y, Zhu J, Shang J, Bai L, Jin Z, Li W, Hu Y, Zheng X, Qian J. Lu M, et al. Front Oncol. 2025 Jan 8;14:1514581. doi: 10.3389/fonc.2024.1514581. eCollection 2024. Front Oncol. 2025. PMID: 39845318 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13,476 results

Search Page

Filters